Johnson & Johnson MedTech Highlights Clinical Evidence for VARIPULSE Platform
The company presents data and hosts educational sessions on the VARIPULSE Platform at APHRS and JHRS.
The VARIPULSE Platform includes the VARIPULSE Catheter, TRUPULSE Generator, and CARTO 3 Mapping System VARIPULSE Software.
The platform is approved for use in the United States, Europe, Asia Pacific, Canada, and Latin America, with over 25,000 procedures performed across these regions.
Johnson & Johnson MedTech is presenting new clinical and real-world evidence from the VARIPULSE Platform, along with hosting scientific symposia, hands-on demonstrations, and educational sessions.
No direct quotes available in the text.
Author's summary: Johnson & Johnson MedTech presents VARIPULSE Platform data.
More News
- Knickerbocker to Host Special Screening of “The Most Precious of Cargoes” Nov. 13–14
- Kimberly-Clark acquires Kenvue in $48.7 billion deal
- WATCH: 'Vanderpump Rules' releases season 12 reboot trailer, meet the new cast!
- Good Vines, Even Better Wines
- Inside Nike and LA Rams’ “In The Field”
- Hilary Duff Announces First New Single in 10 Years
- Cycling Eurovelo 3, from Northern France to Belgium
- New coach leads Genoa to first win of season against Sassuolo
- More Upward Revisions On AI Infrastructure Spending
- Chiefs of staff reveal life with world's most powerful